SS
ABUS icon

SBI Securities’s Arbutus Biopharma ABUS Stock Holding History

SBI Securities’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$74.3K Sell
15,475
-7,191
-32% -$31.6K ﹤0.01% 1027
2026
Q1 		$102K Sell
22,666
-6,959
-23% -$30.4K ﹤0.01% 841
2025
Q4 		$142K Sell
29,625
-13,308
-31% -$59.8K ﹤0.01% 728
2025
Q3 		$195K Sell
42,933
-361
-0.8% -$1.33K 0.01% 635
2025
Q2 		$134K Sell
43,294
-35,600
-45% -$118K ﹤0.01% 719
2025
Q1 		$275K Buy
78,894
+6,614
+9% +$22.1K 0.01% 454
2024
Q4 		$236K Buy
+72,280
New +$266K 0.01% 496

Other funds holding ABUS

TSC
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
WCM
Whitefort Capital Management New York $406M AUM 84.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

SBI Securities's ABUS Position: Q2 2026 in Review

SBI Securities reduced its Arbutus Biopharma (ABUS) stake by 32% in Q2 2026, selling an estimated $31.6K and leaving 15,475 shares worth $74.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1027.

SBI Securities first reported a position in ABUS in Q4 2024 and has held it in 7 quarters since. The position peaked at $275K in Q1 2025. 176 funds tracked by Wall St. Rank hold ABUS as of Q2 2026.

  • SBI Securities held 15,475 shares of Arbutus Biopharma worth $74.3K as of Q2 2026.
  • SBI Securities sold 7,191 Arbutus Biopharma shares in Q2 2026, an estimated $31.6K.
  • Arbutus Biopharma made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #1027 holding.
  • SBI Securities first reported a position in Arbutus Biopharma in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Arbutus Biopharma position peaked at $275K in Q1 2025.
  • 176 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.